RCMT
Rcm Technologies, Inc.
$27.69
+0.18 (+0.65%)
At close · Jul 17
Market Cap
$196.26M
Shares
7,087,614
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$319.4M
+14.7%
FY2025
Net Income
$16.33M
+22.6%
FY2025
Gross Margin
27.53%
-1.1pp
FY2025
Operating Margin
7.86%
-0.2pp
FY2025
Diluted EPS
$2.14
+27.4%
FY2025
Operating Cash Flow
$18.97M
+207.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $317.97M | $319.4M | $278.38M | $263.24M | $284.68M | $203.88M | $150.41M | $191.1M | $200.35M | $186.74M | $176.45M | $185.74M | $193.77M | $170.78M | $145.82M | $143.81M | |
| -$2.64M | -$2.67M | -$2.22M | -$1.4M | -$370K | -$365K | -$778K | -$1.7M | -$1.47M | -$590K | -$539K | -$504K | -$74K | -$55K | -$40K | -$36K | |
| $229.98M | $231.46M | $198.6M | $186.54M | $201.75M | $150.75M | $111.55M | $142.51M | $151.04M | — | — | — | — | — | — | — | |
| $87.99M | $87.94M | $79.78M | $76.7M | $82.93M | $53.12M | $38.86M | $48.59M | $49.31M | $48.39M | $47.03M | $51.89M | $51.69M | $44.36M | $39.72M | $40.74M | |
| — | 27.53% | 28.66% | 29.14% | 29.13% | 26.06% | 25.83% | 25.43% | 24.61% | 25.91% | 26.65% | 27.93% | 26.68% | 25.98% | 27.24% | 28.33% | |
| $61.49M | $60.93M | $56.79M | $52.19M | $53.4M | $42.02M | $37.55M | $40.39M | $40.39M | $40.39M | $40.06M | $42.57M | $39.87M | $35.51M | $33.17M | $32.58M | |
| — | $0 | $136K | $182K | $46K | $95K | $321K | $327K | $125K | $66K | $81K | $82K | $90K | -$116K | -$128K | — | |
| — | $1.92M | $2.1M | $1.21M | $1.04M | $1.1M | $1.39M | $1.59M | $1.57M | $1.76M | $1.57M | $1.47M | $1.2M | $1.11M | $1.32M | $1.15M | |
| — | — | — | — | — | — | — | — | — | — | — | — | $100K | — | — | — | |
| $63.54M | $62.85M | $57.45M | $53M | $54.13M | $38.99M | $49.81M | $42.03M | $43.9M | — | — | — | — | — | — | — | |
| $24.45M | $25.09M | $22.33M | $23.69M | $28.8M | $14.14M | -$10.95M | $6.57M | $5.42M | $280K | $4.12M | $7.85M | $10.52M | $2.56M | $5.23M | $7.01M | |
| — | 7.86% | 8.02% | 9% | 10.12% | 6.93% | -7.28% | 3.44% | 2.7% | 0.15% | 2.33% | 4.23% | 5.43% | 1.5% | 3.59% | 4.87% | |
| — | $27.01M | $24.43M | $24.91M | $29.84M | $15.24M | -$9.56M | $8.16M | $6.98M | $2.04M | $5.68M | $9.32M | $11.72M | $3.67M | $6.55M | $8.16M | |
| -$2.89M | -$3.02M | -$2.14M | -$1.5M | -$318K | -$222K | -$1.11M | -$1.75M | -$1.51M | -$525K | -$813K | -$697K | $83K | $32K | $102K | -$78K | |
| $21.56M | $22.07M | $20.19M | $22.2M | $28.48M | $13.91M | -$12.06M | $4.82M | $3.91M | -$245K | $3.3M | $7.15M | $10.6M | — | — | — | |
| $5.57M | $5.74M | $6.86M | $5.36M | $7.59M | $2.93M | -$3.19M | $764K | $1.19M | -$2.26M | $1.54M | $1.14M | $3.79M | $597K | $2.1M | $2.65M | |
| $15.99M | $16.33M | $13.33M | $16.83M | $20.89M | $10.99M | -$8.87M | $4.06M | $2.72M | $2.01M | $1.76M | $6.02M | $6.81M | $1.99M | $3.23M | $4.28M | |
| — | 5.11% | 4.79% | 6.39% | 7.34% | 5.39% | -5.9% | 2.12% | 1.36% | 1.08% | 1% | 3.24% | 3.52% | 1.17% | 2.21% | 2.97% | |
| — | $16.44M | $13.22M | $16.88M | $20.73M | $10.84M | -$8.67M | $4.07M | $2.36M | $2.19M | $2.03M | $3.08M | $5.92M | $1.44M | $3.29M | $4.17M | |
| USD/shares | — | $2.19 | $1.72 | $2.03 | $2.08 | $1.00 | — | — | — | — | $0.14 | $0.48 | — | — | — | — |
| USD/shares | — | $2.14 | $1.68 | $1.96 | $2.00 | $0.95 | — | $0.22 | $0.22 | — | $0.14 | $0.47 | $0.54 | $0.16 | $0.26 | $0.33 |
| shares | — | 7.45M | 7.74M | 8.31M | 10.05M | 11.04M | 12.15M | 12.91M | 12.33M | 12M | 12.3M | 12.66M | 12.52M | 12.34M | 12.34M | — |
| shares | — | 7.64M | 7.94M | 8.59M | 10.44M | 11.63M | 12.15M | 12.97M | 12.36M | 12.12M | 12.42M | 12.9M | 12.73M | 12.48M | 12.54M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2025: $77.89M in buybacks, $99.46M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Conglomerates median 1.20×
EV/EBIT
—
Conglomerates median 17.11×
P/E (TTM)
13.06×
Conglomerates median 14.00×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | 2021-01-02 |
|---|---|---|---|---|---|---|
| Specialty Health Care | $164,104,000 | $142,679,000 | $136,241,000 | $159,448,000 | $98,495,000 | $60,481,000 |
| Engineering | $120,486,000 | $96,459,000 | $84,675,000 | $85,937,000 | $66,172,000 | $57,715,000 |
| Life Sciences Data Solutions | $34,814,000 | $39,242,000 | $42,321,000 | — | — | — |
| Corporate | $0 | $0 | $0 | $0 | $0 | $0 |
| Life Sciences and IT | — | — | — | $39,295,000 | $39,208,000 | $32,213,000 |
By Geography (USD)
| Component | 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | 2021-01-02 |
|---|---|---|---|---|---|---|
| United States | $290,187,000 | $256,759,000 | $246,578,000 | $272,342,000 | $186,169,000 | $126,238,000 |
| Europe | $15,319,000 | $7,408,000 | $3,664,000 | $2,630,000 | $2,891,000 | — |
| Canada | $7,535,000 | $7,196,000 | $6,480,000 | $4,708,000 | $9,578,000 | $15,310,000 |
| Puerto Rico | $6,363,000 | $7,017,000 | $6,515,000 | $5,180,000 | $5,237,000 | $5,702,000 |
| Philippines | — | — | $0 | — | — | — |
| Serbia | — | — | — | — | — | $3,159,000 |
By Product & Service (USD)
| Component | 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | 2021-01-02 |
|---|---|---|---|---|---|---|
| Health Care | $164,104,000 | $142,679,000 | $136,241,000 | $159,448,000 | $98,495,000 | $60,481,000 |
| Engineering Services | $120,486,000 | $96,459,000 | $84,675,000 | $85,937,000 | $66,172,000 | $57,715,000 |
| Technology Service | $34,814,000 | $39,242,000 | $42,321,000 | $39,295,000 | $39,208,000 | $32,213,000 |
| Service | $1,700,000 | $1,700,000 | — | — | — | — |
| Service Other | — | $1,500,000 | $1,700,000 | $2,200,000 | $1,800,000 | $1,500,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | 2021-01-02 |
|---|---|---|---|---|---|---|
| Specialty Health Care | $22,789,000 | $19,934,000 | $13,539,000 | $19,818,000 | $5,455,000 | -$2,555,000 |
| Engineering | $14,635,000 | $10,061,000 | $3,531,000 | $4,299,000 | $5,370,000 | -$5,889,000 |
| Life Sciences Data Solutions | $6,317,000 | $8,753,000 | $6,622,000 | — | — | — |
| Corporate | -$18,648,000 | -$16,423,000 | $0 | $0 | $0 | -$2,231,000 |
| Information Technology | — | — | — | — | $3,331,000 | — |
| Life Sciences and IT | — | — | — | $4,681,000 | — | -$275,000 |
Operating Margin by Segment (%)
| Component | 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | 2021-01-02 |
|---|---|---|---|---|---|---|
| Specialty Health Care | 13.9% | 14% | 9.9% | 12.4% | 5.5% | -4.2% |
| Engineering | 12.1% | 10.4% | 4.2% | 5% | 8.1% | -10.2% |
| Life Sciences Data Solutions | 18.1% | 22.3% | 15.6% | — | — | — |
| Life Sciences and IT | — | — | — | 11.9% | — | -0.9% |